Adaptimmune Therapeutics PLC 10-Q for FY2024 Q2
Adaptimmune Therapeutics PLC (ADAPY)
10-Q
2024-08-12
For: 2024-06-30
View Original
Added on
June 11, 2026
About this 10-Q
Adaptimmune Therapeutics PLC filed this 10-Q on August 12, 2024, covering the quarter ended June 30, 2024 (FY2024 Q2).
Headline figures
Quarter ended June 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $128.23M
- up 2399.6% from $5.13M a year earlier
- Net income
- $69.52M
- compared with a net loss of $21.39M a year earlier
- Diluted EPS
- $0.04
- compared with -$0.02 a year earlier